Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer

NCT02348450 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

308

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Irinotecan
DRUG: Etoposide
DRUG: Cisplatin

Sponsor

Guangdong Association of Clinical Trials